166 related articles for article (PubMed ID: 36656512)
1. Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecular Imaging Approach.
Houvast RD; van Duijvenvoorde M; Chua J; Vankemmelbeke M; Durrant LG; Inderson A; van Hooft JE; Mieog JSD; Bonsing BA; Sier CFM; Crobach ASLP; Vahrmeijer AL; Kuppen PJK
Mol Diagn Ther; 2023 Mar; 27(2):261-273. PubMed ID: 36656512
[TBL] [Abstract][Full Text] [Related]
2. Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment.
Vuijk FA; de Muynck LDAN; Franken LC; Busch OR; Wilmink JW; Besselink MG; Bonsing BA; Bhairosingh SS; Kuppen PJK; Mieog JSD; Sier CFM; Vahrmeijer AL; Verheij J; Fariňa-Sarasqueta A; Swijnenburg RJ
Sci Rep; 2020 Oct; 10(1):16211. PubMed ID: 33004930
[TBL] [Abstract][Full Text] [Related]
3. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
Gan Q; Roy-Chowdhuri S; Duose DY; Stewart JM; Coronel E; Bhutani MS; Lee JH; Weston B; Ge PS; Ross WA; Maitra A
Cancer Cytopathol; 2022 Apr; 130(4):275-283. PubMed ID: 34905283
[TBL] [Abstract][Full Text] [Related]
4. An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma.
Houvast RD; Thijse K; Groen JV; Chua J; Vankemmelbeke M; Durrant LG; Mieog JSD; Bonsing BA; Vahrmeijer AL; Kuppen PJK; Crobach ASLP; Sier CFM
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830932
[TBL] [Abstract][Full Text] [Related]
5. Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pancreatic cancer.
Larghi A; Correale L; Ricci R; Abdulkader I; Monges G; Iglesias-Garcia J; Giovannini M; Attili F; Vitale G; Hassan C; Costamagna G; Rindi G
Endoscopy; 2015 Apr; 47(4):308-14. PubMed ID: 25521572
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens.
Razzano D; Bouza SJ; Hernandez PV; Wang M; Robert ME; Walther Z; Cai G
Cancer Cytopathol; 2022 Sep; 130(9):726-734. PubMed ID: 35511415
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.
Chu CS; Yang CY; Yeh CC; Lin RT; Chen CC; Bai LY; Hung MC; Lin CC; Wu CY; Lin JT
Sci Rep; 2022 Jan; 12(1):107. PubMed ID: 34997106
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC).
Le K; Wang J; Zhang T; Guo Y; Chang H; Wang S; Zhu B
Int J Med Sci; 2020; 17(4):422-427. PubMed ID: 32174772
[No Abstract] [Full Text] [Related]
9. Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma.
Tummers WS; Farina-Sarasqueta A; Boonstra MC; Prevoo HA; Sier CF; Mieog JS; Morreau J; van Eijck CH; Kuppen PJ; van de Velde CJ; Bonsing BA; Vahrmeijer AL; Swijnenburg RJ
Oncotarget; 2017 Aug; 8(34):56816-56828. PubMed ID: 28915633
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.
Sopha SC; Gopal P; Merchant NB; Revetta FL; Gold DV; Washington K; Shi C
Int J Clin Exp Pathol; 2013; 6(11):2476-86. PubMed ID: 24228110
[TBL] [Abstract][Full Text] [Related]
11. EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Cao C; Kong MX; Kapali M; Moezardalan K; Shi Q; Azarm A; Lai J
Anticancer Res; 2020 Aug; 40(8):4401-4404. PubMed ID: 32727769
[TBL] [Abstract][Full Text] [Related]
12. Cancer-cell-derived sialylated IgG as a novel biomarker for predicting poor pathological response to neoadjuvant therapy and prognosis in pancreatic cancer.
Cui M; Shoucair S; Liao Q; Qiu X; Kinny-Köster B; Habib JR; Ghabi EM; Wang J; Shin EJ; Leng SX; Ali SZ; Thompson ED; Zimmerman JW; Shubert CR; Lafaro KJ; Burkhart RA; Burns WR; Zheng L; He J; Zhao Y; Wolfgang CL; Yu J
Int J Surg; 2023 Feb; 109(2):99-106. PubMed ID: 36799816
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
[TBL] [Abstract][Full Text] [Related]
14. Concordance of the histological diagnosis of type 1 autoimmune pancreatitis and its distinction from pancreatic ductal adenocarcinoma with endoscopic ultrasound-guided fine needle biopsy specimens: an interobserver agreement study.
Notohara K; Kamisawa T; Furukawa T; Fukushima N; Uehara T; Kasashima S; Iwasaki E; Kanno A; Kawashima A; Kubota K; Kuraishi Y; Motoya M; Naitoh I; Nishino T; Sakagami J; Shimizu K; Tomono T; Aishima S; Fukumura Y; Hirabayashi K; Kojima M; Mitsuhashi T; Naito Y; Ohike N; Tajiri T; Yamaguchi H; Fujiwara H; Ibuki E; Kobayashi S; Miyaoka M; Nagase M; Nakashima J; Nakayama M; Oda S; Taniyama D; Tsuyama S; Watanabe S; Ikeura T; Kawa S; Okazaki K
Virchows Arch; 2022 Mar; 480(3):565-575. PubMed ID: 34820715
[TBL] [Abstract][Full Text] [Related]
15. Standardized Methods Using EUS-guided Fine-needle Biopsy and a Minimal Medium Creates Three Pancreatic Cancer Organoids.
Ishida Y; Tsunoda T; Hamada Y; Tsuchiya N; Koga T; Kitaguchi T; Matsumoto K; Matsumoto S; Sasaki T; Nakashima R; Ishii F; Kajiwara M; Shirasawa S; Hasegawa S; Hirai F
Anticancer Res; 2022 Aug; 42(8):4103-4109. PubMed ID: 35896269
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a patient-specific avatar organoid model derived from endoscopic ultrasonography-guided fine needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma.
Kim H; Jang J; Choi JH; Song JH; Lee SH; Park J; Ryoo SK; Lee EM; Jeong HO; Kim S; Lee SH; Lee KH; Lee KT; Kim KM; Jang KT; Lee H; Lee S; Lee JK; Park JK
Gastrointest Endosc; 2024 Mar; ():. PubMed ID: 38447660
[TBL] [Abstract][Full Text] [Related]
17. Mesothelin and TGF-α predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib.
Poteet E; Liu D; Liang Z; Van Buren G; Chen C; Yao Q
PLoS One; 2019; 14(3):e0213294. PubMed ID: 30921351
[TBL] [Abstract][Full Text] [Related]
18. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
Nahm CB; Turchini J; Jamieson N; Moon E; Sioson L; Itchins M; Arena J; Colvin E; Howell VM; Pavlakis N; Clarke S; Samra JS; Gill AJ; Mittal A
Eur J Surg Oncol; 2019 Feb; 45(2):218-224. PubMed ID: 30348604
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients with Pancreatic Ductal Adenocarcinoma (PDAC).
Constantin A; Iovănescu V; Cazacu IM; Ungureanu BS; Copăescu C; Stroescu C; Bejinariu N; Săftoiu A
Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204385
[TBL] [Abstract][Full Text] [Related]
20. Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer.
Elhanafi S; Mahmud N; Vergara N; Kochman ML; Das KK; Ginsberg GG; Rajala M; Chandrasekhara V
J Gastroenterol Hepatol; 2019 May; 34(5):907-913. PubMed ID: 30422342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
